Cognoptix Release: “2015 World Medical Innovation Forum” Cites “Early Diagnosis And Treatment Of Alzheimer’s Disease” As The Top Field Where Breakthroughs Will Be Made

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix Chairman, CEO and President Paul Hartung is encouraged by recent clinical developments in the early treatment of Alzheimer’s disease and reiterated that his company is accelerating development of its Sapphire II eye scan to enable identification of candidates for these disease-modifying treatments. Mr. Hartung was especially pleased by the enthusiasm among clinicians at the recently convened “2015 World Medical Innovation Forum” in Boston hosted by Partners Healthcare.

Help employers find you! Check out all the jobs and post your resume.

Back to news